Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Status of COVID-19 vaccine development.
Taxt AM, Grødeland G, Lind A, Müller F. Taxt AM, et al. Among authors: grodeland g. Tidsskr Nor Laegeforen. 2020 Sep 9;140(13). doi: 10.4045/tidsskr.20.0676. Print 2020 Sep 29. Tidsskr Nor Laegeforen. 2020. PMID: 32998488 Free article. English, Norwegian.
[How effective is the COVID-19 vaccine for older persons?].
Vaksdal HH, Grødeland G. Vaksdal HH, et al. Among authors: grodeland g. Tidsskr Nor Laegeforen. 2021 Nov 15;141(18). doi: 10.4045/tidsskr.21.0748. Print 2021 Dec 14. Tidsskr Nor Laegeforen. 2021. PMID: 34911279 Free article. Norwegian. No abstract available.
[Efficacy of three doses of COVID-19 vaccine].
Vaksdal HH, Grødeland G. Vaksdal HH, et al. Among authors: grodeland g. Tidsskr Nor Laegeforen. 2022 Feb 18;142(5). doi: 10.4045/tidsskr.22.0096. Print 2022 Mar 22. Tidsskr Nor Laegeforen. 2022. PMID: 35324133 Free article. Norwegian. No abstract available.
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity.
Søraas A, Grødeland G, Granerud BK, Ueland T, Lind A, Fevang B, Murphy SL, Huse C, Nygaard AB, Steffensen AK, Al-Baldawi H, Holberg-Petersen M, Andresen LL, Ågnes C, Ranheim T, Schanke Y, Istre M, Dahl JA, Chopra A, Dudman S, Kaarbø M, Andersen JT, Vaage EB, Tran TT, Vaage JT, Michelsen AE, Müller F, Aukrust P, Halvorsen B, Dahl TB, Holter JC, Lund-Johansen F. Søraas A, et al. Among authors: grodeland g. Front Immunol. 2022 Sep 8;13:964525. doi: 10.3389/fimmu.2022.964525. eCollection 2022. Front Immunol. 2022. PMID: 36159859 Free PMC article.
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants.
Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K, Thomassen KS, Kro GB, Cox RJ, Zhou F, Langeland N, Aukrust P, Melum E, Åvitsland TL, Wiencke K, Holter JC, Munthe LA, Grødeland G, Andersen JT, Vaage JT, Lund-Johansen F. Tran TT, et al. Among authors: grodeland g. NPJ Vaccines. 2022 Dec 30;7(1):174. doi: 10.1038/s41541-022-00586-7. NPJ Vaccines. 2022. PMID: 36585405 Free PMC article.
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants.
Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K, Thomassen KS, Kro GB, Cox RJ, Zhou F, Langeland N, Aukrust P, Melum E, Åvitsland TL, Wiencke K, Holter JC, Munthe LA, Grødeland G, Andersen JT, Vaage JT, Lund-Johansen F. Tran TT, et al. Among authors: grodeland g. NPJ Vaccines. 2023 Jan 25;8(1):4. doi: 10.1038/s41541-023-00600-6. NPJ Vaccines. 2023. PMID: 36697432 Free PMC article. No abstract available.
[The vaccines can keep up with the SARS-CoV-2 mutations].
Andersen TK, Grødeland G. Andersen TK, et al. Among authors: grodeland g. Tidsskr Nor Laegeforen. 2021 Feb 1;141(3). doi: 10.4045/tidsskr.21.0080. Print 2021 Feb 23. Tidsskr Nor Laegeforen. 2021. PMID: 33624975 Free article. Norwegian. No abstract available.
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.
Ørbo HS, Bjørlykke KH, Sexton J, Jyssum I, Tveter AT, Christensen IE, Mjaaland S, Kvien TK, Grødeland G, Kro GB, Jahnsen J, Haavardsholm EA, Munthe LA, Provan SA, Vaage JT, Goll GL, Jørgensen KK, Syversen SW. Ørbo HS, et al. Among authors: grodeland g. RMD Open. 2024 Apr 9;10(2):e003545. doi: 10.1136/rmdopen-2023-003545. RMD Open. 2024. PMID: 38599653 Free PMC article.
[Menstrual abnormalities after COVID-19 vaccination].
Mahalingam S, Grødeland G. Mahalingam S, et al. Among authors: grodeland g. Tidsskr Nor Laegeforen. 2022 Jun 13;142(9). doi: 10.4045/tidsskr.22.0217. Print 2022 Jun 14. Tidsskr Nor Laegeforen. 2022. PMID: 35699538 Free article. Norwegian. No abstract available.
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study.
Christensen IE, Jyssum I, Tveter AT, Sexton J, Tran TT, Mjaaland S, Kro GB, Kvien TK, Warren DJ, Jahnsen J, Munthe LA, Haavardsholm EA, Vaage JT, Grødeland G, Lund-Johansen F, Jørgensen KK, Syversen SW, Goll GL, Provan SA. Christensen IE, et al. Among authors: grodeland g. BMC Med. 2022 Oct 5;20(1):378. doi: 10.1186/s12916-022-02587-8. BMC Med. 2022. PMID: 36199139 Free PMC article.
45 results